These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15877531)
1. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle. Newton HB Expert Rev Anticancer Ther; 2005 Apr; 5(2):355-78. PubMed ID: 15877531 [TBL] [Abstract][Full Text] [Related]
2. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway. Newton HB Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449 [TBL] [Abstract][Full Text] [Related]
3. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Newton HB Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572 [TBL] [Abstract][Full Text] [Related]
4. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness. Newton HB Expert Rev Anticancer Ther; 2004 Oct; 4(5):803-21. PubMed ID: 15485315 [TBL] [Abstract][Full Text] [Related]
5. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways. Newton HB Expert Rev Anticancer Ther; 2003 Oct; 3(5):595-614. PubMed ID: 14599084 [TBL] [Abstract][Full Text] [Related]
6. Targeting cell cycle and apoptosis for the treatment of human malignancies. Senderowicz AM Curr Opin Cell Biol; 2004 Dec; 16(6):670-8. PubMed ID: 15530779 [TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors in children with malignant gliomas. Herrington B; Kieran MW Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732 [TBL] [Abstract][Full Text] [Related]
9. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518 [TBL] [Abstract][Full Text] [Related]
10. Small molecule signal transduction inhibitors for the treatment of solid tumors. Leary A; Johnston SR Cancer Invest; 2007 Aug; 25(5):347-65. PubMed ID: 17661211 [TBL] [Abstract][Full Text] [Related]
11. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis. Newton HB Expert Rev Anticancer Ther; 2004 Feb; 4(1):105-28. PubMed ID: 14748662 [TBL] [Abstract][Full Text] [Related]
12. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Maddika S; Ande SR; Panigrahi S; Paranjothy T; Weglarczyk K; Zuse A; Eshraghi M; Manda KD; Wiechec E; Los M Drug Resist Updat; 2007; 10(1-2):13-29. PubMed ID: 17303468 [TBL] [Abstract][Full Text] [Related]
13. Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations. Broxterman HJ; Georgopapadakou NH Drug Resist Updat; 2005 Aug; 8(4):183-97. PubMed ID: 16154800 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis modulators as cancer therapeutics. Penn LZ Curr Opin Investig Drugs; 2001 May; 2(5):684-92. PubMed ID: 11569948 [TBL] [Abstract][Full Text] [Related]
15. New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective. Awada A; Mano M; Hendlisz A; Piccart M Expert Rev Anticancer Ther; 2004 Feb; 4(1):53-60. PubMed ID: 14748657 [TBL] [Abstract][Full Text] [Related]
16. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma. Younes H; Leleu X; Hatjiharissi E; Moreau AS; Hideshima T; Richardson P; Anderson KC; Ghobrial IM Clin Cancer Res; 2007 Jul; 13(13):3771-5. PubMed ID: 17606706 [TBL] [Abstract][Full Text] [Related]
17. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Faivre S; Djelloul S; Raymond E Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796 [TBL] [Abstract][Full Text] [Related]
18. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578 [TBL] [Abstract][Full Text] [Related]